Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 89 results found. Search for [ Swiss drug ]

Results 1 to 21 of 89
PTI
January 18, 2019
Last week, Trump cancelled his planned trip to the World Economic Forum (WEF meeting), citing the \"intransigence\" of the Democrats on his funding request to build a controversial wall along the US-Mexico border.


PTI
January 18, 2019



PB Jayakumar
New Delhi, January 9, 2019
Ogivri is the biosimilar version of Swiss drug maker Roches Herceptin, a breast cancer and gastric cancer drug with sales of $6.9 billion a year worldwide


PTI
December 31, 2018
Industry players expect more partnerships in the new year between public and the private sector in the healthcare space, which they feel is 'under-invested'


PTI
December 31, 2018



PTI
December 21, 2018



PB Jayakumar
December 19, 2018
Ogivri (Trastuzumab), jointly developed by Biocon and Mylan, is the biosimilar version of Swiss drug maker Roche's Herceptin.


PTI
December 19, 2018



PTI
December 6, 2018



Team BT
New Delhi, June 25, 2018
Indian promoters take home fat pay cheques but their compensation is, in most cases, linked to company performance.


PTI
April 4, 2018



PTI
January 10, 2018



PTI
January 10, 2018



PTI
January 10, 2018



E. Kumar Sharma
New Delhi, January 10, 2018
By following the strategy of doing a few things well, V.C. Nannapaneni has helped Natco Pharma carve out a space for itself.


PTI
January 4, 2018



BusinessToday.in
November 30, 2017
Of 30 Sensex stocks, 26 are trading in the red. Sun Pharma (0.82 percent), Bajaj Auto (0.56 percent), Dr Reddy's (0.31 percent) top gainers.


E. Kumar Sharma
Delhi, April 1, 2017
Leading Indian pharmaceutical companies are facing competition in the US from relatively smaller firms back home.


Mail Today Bureau
Zurich, January 27, 2017
The acquisition gives J&J access to the Swiss group's line-up of highprice, high-margin medicines for rare diseases, helping it diversify its drug portfolio as its biggest product, Remicade for arthritis, faces cheaper competition.


By Joe C. Mathew
September 15, 2016
A high-level panel set up to advise the UN Secretary-General on improving access to medicines has called for measures to correct policy incoherencies that are denying access to essential medicines and health technologies to millions of poor across the world.


PAGES 1 OF 5  12345